Janet Tomiyama, PhD, a health psychologist at the University of California, Los Angeles, wrote in a 2025 commentary, (GLP-1s) have the potential to increase weight stigma, medicalize larger bodies, and shame people for both taking the perceived easy way outor not taking it
Many may need to continue taking GLP-1 medications in order to maintain their weight loss and health goals The doses of medication may stay the same or may be reduced to find the lowest effective dose that maintains weight and health Lifestyle and behavioural changes in the maintenance phase are crucial Any reduction or stopping of GLP-1 medication should be done under medical supervision, gradually Monitor weight and appetite vigilantly Many people will find that they can use a reduced dose of GLP-1 medication once they have achieved their target BMI
Bright Yellow Pee Is a Sign of Absorption, Not Waste Some people worry that neon yellow urine means their supplement is being wasted
Free radicals are dangerous because they can cause a process called "oxidative stress," which is an imbalance between the antioxidants and free radicals in the body and is thought to play a role in certain diseases, like cancer
Kant, dknt veya mide problemleri gibi belirtiler grlrse kullanma son verilip bir uzmana bavurulmaldr
According to the Summary of Product Characteristics (SmPC) for these medications, headache is classified as very common (affecting more than 1 in 10 people) with weight-management doses of GLP-1 receptor agonists such as Wegovy (semaglutide 2.4 mg) and Saxenda (liraglutide 3 mg)
